Braveheart Bio, Inc.

Nasdaq: BRVEGrowth candidate

65 days public · Pharmaceutical Preparations · $20.02 (+4.87%)

Growth candidate RANKED

/ 100 fit

Confidence100%

Braveheart Bio, Inc. (BRVE) is ranked for the Growth strategy based on an intelligence score of 67 and a deterministic strategy-fit of 69/100, driven by strong institutional backing and positive short-term momentum.

Intelligence score

/ 100 core

Suggested alloc

30%

cap · your limits

Days public

EARLY PUBLIC

Last price

$20.02

live quote

1d change

+4.87%

session

Why selectedLIVE

EQUENCY Reasoning Engine

+Institutional ownership is high with 4 Schedule 13D and 13G disclosures on file with the SEC, resulting in an institutional score of 93.
+Positive near-term market momentum is evidenced by a 4.87% one-day price move.
+Active corporate and insider communication is reflected by 2 8-K filings and 29 insider forms.

RisksLIVE